Bain Capital Life Sciences Opportunities III, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON)

Filing Manager
Bain Capital Life Sciences Opportunities III, LP
Reporting Manager
Bain Capital Life Sciences Opportunities III, LP
Security
Disc Medicine, Inc. Common Stock, $0.0001 par value per share
Symbol
IRON
Shares outstanding
29,803,030 shares
Disclosed Ownership
983,500 shares
Ownership
3.3%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 07:50:47 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Quoteable Key Fact

"Bain Capital Life Sciences Opportunities III, LP disclosed 3.3% ownership in Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON) on 31 Dec 2024."

Quick Takeaways

  • Bain Capital Life Sciences Opportunities III, LP filed SCHEDULE 13G/A for Disc Medicine, Inc. Common Stock, $0.0001 par value per share (IRON).
  • Disclosed ownership: 3.3%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 07:50.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bain Capital Life Sciences Opportunities III, LP 3.3% 983,500 0 983,500 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC